Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Don’t sell any here/ but Ura Holdings (URAH) are going into production before end of month/ will be huge /. 100s millions worth of emeralds / very small market cap / Do some research
By
I don’t think we will have to wait long for more trials to be announced/ I’m very excited buy my investment here and looking to add on a monthly basis
A key focus for Ananda is developing the evidence required to prove the efficacy of its cannabinoid medicines, and we are motivated by the calls of UK regulators for evidence to unlock NHS funding.
MRX Medical is providing one of its cannabidiol formulations, MRX1, into two Phase II clinical trials that have received a combined £1.55 million in non-dilutive funding.
One of the clinical trials will use one of our formulations to target the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN), which approximately 160,000 people in the UK are diagnosed with each year. The other trial will use the same formulation to target the treatment of the pain associated with endometriosis, which is suffered by 1.5 million women in the UK.
In addition to these funded trials, Ananda continues to develop a pipeline of opportunities to further build evidence through clinical trials.
Despite very strict cannabis regulations in Japan, some cannabidiol (CBD) products have been legally distributed since 2013 and taken by some patients with epilepsy.
A self-administered questionnaire was sent to 38 patients with intractable epilepsy who were taking CBD
The median CBD intake was 12.0 mg/kg/day NB: Product was CBD isolate.
Fifteen patients (53.6%) reported a decrease in seizure frequency. Moreover, two patients (7.1%) showed complete resolution of seizures.
No significant correlation was found between the patient’s diagnosis and seizure type or treatment efficacy.
Conclusions: This is the first cross-sectional study of CBD users in Japan suggesting that CBD may be an effective option for Asian patients with refractory epilepsy, regardless of diagnosis or seizure type.
Very strong chance I'd say given the stance of Ananda and the way they are doing exactly what is required gold std wise along with the recent SAB that's been assembled too!
5. Innovation in Healthcare: With an open policy, the UK could become a leader in cannabis-based treatment innovation, attracting researchers, pharmaceutical companies, & investors interested in developing new therapeutic products. This could lead to the creation of novel drug formulations & delivery systems, further expanding treatment options for patients.
Yep looks like he talked a few peeps in
2k total pays for the trip I guess
And it's getting busy with several people already engaging with Mellisa and Jeremy prior to Jeremy taking the Stage at 10.30 you vould say this will draw in many new investors
True but it makes no difference unless you have herd mentality .
With the spread being so tight today and yesterday between 0.31 and 0.30, buys are being shown in error as sells and unknown
Someone happy to take the sellers shares!
3M shares sold in late trading - who and why?
I see the Bod fully committed on personal multi million funds within this company and working hard to align multiple rcts to fulfill guidance set out by governing bodies to prove pain relief is controlled within different conditions by real data collected which will be better all round for patients and The NHS on its current spend with out success! Timing is every and perhaps your buys time wise weren't the best! As for the temporary haul on the grow facility at mid stage, this turns out to be a masterclass as we are now going to continue on 3rd party funding instead of our own! Pretty smart business model all round I'd say on the stabilisation side and rct's whilst retaining all ip and commercial rights!
I too have much dwindled pot pompey , if as i now suspect this is a life style comp taking us for fools , i expect a consolidation next then a share issue and bye bye rest [which is only 20% left] of pot ,and before anyone says why dont you f off then ,it aint worth bothering about ,when 80% has slid away already ,written off ,but just maybe i am wrong ,
Haven't posted for some time but still hold a much dwindled pot. I'm still upbeat about the company but I was disappointed when it suddenly announced it was becoming pharma, rather than farmer. I've my fingers crossed for the pharma stuff but it hasn't excited like the 200 tonnes of cannabis they said they were going to grow in a big new facility with djt. With a pure micro pharma play now, I can't help thinking I bought in 10 years too soon. Hope I'm wrong, but good luck all us LTHs.
All signed ! Very nice many more to come I'd say